Aramark Reports Third Quarter Results

Q3 SUMMARY

  • Revenue $4 billion, +1.0%; Legacy Business Revenue +3.7%1
  • Operating Income +1%; Adjusted Operating Income (AOI) +4%1
  • EPS +14% to $0.33; Adjusted EPS +14%1 to $0.47
  • Reduced net debt position by $672 million versus prior year
  • Board authorizes share repurchase program of $200M through 2022

PHILADELPHIA--()--Aramark (NYSE: ARMK) today reported third quarter fiscal 2019 results.

“Our performance in the third quarter was strong and broad-based, anchored in a relentless focus on innovative growth strategies that directly engage the millions of consumers we serve every day,” said Eric J. Foss, Aramark’s Chairman, President and CEO. "We continue to advance our brand and product offerings as part of our commitment to combine technology, convenience and curation across our portfolio. This disciplined approach, combined with the exemplary efforts of our global team members, drove solid year-to-date results, positioning us well to achieve our full year expectations.

“The foundation we are creating provides us with ample opportunity to infuse sales growth and optimize our investments to scale the business,” Foss added. “As a testament to our enhanced financial flexibility, our Board has authorized a share repurchase program. Collectively, these purposeful strategies fuel our ability to drive value creation for our stakeholders."

1 Constant Currency.

THIRD QUARTER RESULTS*

Consolidated Revenue was $4.0 billion in the quarter, an increase of 1.0%. Adjusted Revenue grew 5.8% over the prior-year, attributed to a 3.7% growth in the legacy business and a 2.1% increase related to an accounting rule change. Legacy Revenue expansion was driven by new business wins and base business growth across the segments:

  • FSS United States growth of 1.5% led by strength in stadiums and arenas as well as business dining.
  • FSS International increase of 9.8% due to growth across geographies with particularly strong performance in Europe, South America and China.
  • Uniform & Career Apparel grew 3.1% from improved pricing and volume as well as the continued integration of AmeriPride into the portfolio.

 

Revenue

 

Q3 '19

Q3 '18

Change

Adjusted Revenue Change

Legacy Revenue Change

FSS United States1

$2,414M

$2,501M

(3.5)%

0.9%

1.5%

FSS International

950

930

2.2%

10.0%

9.8%

Uniform & Career Apparel

647

541

19.7%

20.1%

3.1%

Total Company

$4,011M

$3,972M

1.0%

5.8%

3.7%

Difference between GAAP Revenue and Adjusted Revenue reflects the elimination of currency translation and divestitures impact.

Difference between Adjusted Revenue and Legacy Revenue reflects the accounting rule changes pursuant to ASC 606.

1

Q3 '18 GAAP results include divested Healthcare Technologies revenue of $107 million. This has been excluded from the calculation of adjusted revenue change and legacy revenue change for comparison purposes.

Operating Income was $189 million, up 1% compared to the prior-year period. Adjusted Operating Income increased 4% on a constant currency basis, driven by operational improvements and acquisition synergies, offset by higher total incentive-based compensation and the deliberate exit of non-core custodial accounts in Europe. Notwithstanding these items:

  • FSS United States exhibited operational efficiencies from greater purchasing scale and productivity improvement in the base business.
  • FSS International demonstrated broad-based growth with particular strength in Canada and Emerging Markets.
  • Uniform & Career Apparel capitalized on synergies related to the AmeriPride acquisition with additional efficiency from operational performance.

Total incentive-based compensation, referenced above, included both share-based and cash incentives for employees. The Corporate segment reflected lower share-based compensation with all segments affected by higher cash incentive compensation.

 

Operating Income

 

Adjusted Operating Income

 

Q3 '19

Q3 '18

Change

 

Q3 '19

Q3 '18

Constant-Currency Change

FSS United States2

$128M

$136M

(6)%

 

$156M

$155M

1%

FSS International

40

44

(8)%

 

43

47

(4)%

Uniform & Career Apparel

54

57

(6)%

 

67

70

(4)%

Corporate

(33)

(49)

34%

 

(29)

(42)

31%

Total Company

$189M

$187M

1%

 

$237M

$231M

4%

2

Q3 '18 GAAP results include divested Healthcare Technologies operating income of $8 million. This has been excluded from the calculation of Adjusted Operating Income constant-currency change for comparison purposes.

*

May not total due to rounding.

GAAP SUMMARY

On a GAAP basis, revenue was $4.0 billion, operating income was $189 million, net income attributable to Aramark stockholders was $83 million, and diluted earnings per share were $0.33. This compares to the third quarter of 2018 where revenue was $4.0 billion, operating income was $187 million, net income attributable to Aramark stockholders was $73 million and diluted earnings per share were $0.29. Third quarter GAAP diluted earnings per share increased 14% year-over-year. As of the end of the third quarter net cash provided by operating activities was $208 million year-to-date compared to the prior year total of $146 million.

CAPITAL STRUCTURE & FREE CASH FLOW

The Company made continued progress in de-leveraging by reducing its net debt position by $672 million compared to the prior year. Total trailing 12-month net debt to covenant adjusted EBITDA was 4.1x at the end of the quarter, a 0.5x improvement versus the end of the third quarter of 2018. Through nine months, Free Cash Flow improved $158 million compared to prior year. This increase can be attributed to a disciplined management of working capital and investment spend. At quarter-end the Company had approximately $1.1 billion in cash and availability on its revolving credit facility.

SHARE REPURCHASE

Subsequent to the end of the third quarter, the Board approved a share repurchase program of up to $200 million of Aramark's common stock. Repurchases may be made from time to time on the open market or through privately negotiated transactions. The repurchase program has been authorized through July 2022.

CURRENCY

A stronger U.S. dollar decreased revenue by approximately $77 million and had a negative impact of approximately $3 million on operating income. It also had a one-cent unfavorable impact on GAAP and adjusted earnings per share.

2019 OUTLOOK

Aramark provides its expectations for legacy business revenue growth, full-year adjusted EPS and full-year free cash flow on a non-GAAP basis, and does not provide a reconciliation of such forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations, including adjustments that could be made for the impact of the change in fair value related to certain gasoline and diesel agreements, severance and other charges and the effect of currency translation.

The Company maintains the following performance outlook for Fiscal 2019:

  • Legacy business revenue growth expectations of approximately 3%.
  • Adjusted EPS of $2.20 to $2.30 per share. This includes four cents of unfavorable currency impact.
  • Free cash flow of $500 million. This includes approximately $50 million in cash outlay related to the divestiture of the Healthcare Technologies business and approximately $50 million in spending on the integrations of Avendra and AmeriPride.
  • Net debt to covenant adjusted EBITDA of 3.8x by the end of the fiscal year.

CONFERENCE CALL SCHEDULED

The Company has scheduled a conference call at 8:30 a.m. ET today to discuss its earnings and outlook. This call and related materials can be heard and reviewed, either live or on a delayed basis, on the Company's web site, www.aramark.com on the investor relations page.

About Aramark

Aramark (NYSE: ARMK) proudly serves Fortune 500 companies, world champion sports teams, state-of-the-art healthcare providers, the world’s leading educational institutions, iconic destinations and cultural attractions, and numerous municipalities in 19 countries around the world. Our 270,000 team members deliver experiences that enrich and nourish millions of lives every day through innovative services in food, facilities management and uniforms. We work to put our sustainability goals into action by focusing on initiatives that engage our employees, empower healthy living, preserve our planet and build local communities. Aramark is recognized as one of the World’s Most Admired Companies by FORTUNE, as well as an employer of choice by the Human Rights Campaign and DiversityInc. Learn more at www.aramark.com or connect with us on Facebook and Twitter.

Selected Operational and Financial Metrics

Adjusted Revenue

Adjusted Revenue represents revenue growth, adjusted to eliminate the impact of currency translation and divestitures.

Legacy Business Revenue

Legacy Business Revenue represents Adjusted Revenue, excluding the revenue of AmeriPride and Avendra that is not comparable to the prior year periods and the impact of the adoption of Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers.

Adjusted Operating Income

Adjusted Operating Income represents operating income adjusted to eliminate the change in amortization of acquisition-related intangible assets; the impact of the change in fair value related to certain gasoline and diesel agreements; severance and other charges; the effect of divestitures (including the gain on the sale); merger and integration related charges; tax reform related employee reinvestments; and other items impacting comparability.

Adjusted Operating Income (Constant Currency)

Adjusted Operating Income (Constant Currency) represents Adjusted Operating Income adjusted to eliminate the impact of currency translation.

Adjusted Net Income

Adjusted Net Income represents net income attributable to Aramark stockholders adjusted to eliminate the change in amortization of acquisition-related intangible assets; the impact of changes in the fair value related to certain gasoline and diesel agreements; severance and other charges; merger and integration related charges; the effect of divestitures (including the gain on the sale); the effects of refinancings on interest and other financing costs, net; the impact of tax reform and other items impacting comparability, less the tax impact of these adjustments. The tax effect for adjusted net income for our U.S. earnings is calculated using a blended U.S. federal and state tax rate. The tax effect for adjusted net income in jurisdictions outside the U.S. is calculated at the local country tax rate.

Adjusted Net Income (Constant Currency)

Adjusted Net Income (Constant Currency) represents Adjusted Net Income adjusted to eliminate the impact of currency translation.

Adjusted EPS

Adjusted EPS represents Adjusted Net Income divided by diluted weighted average shares outstanding.

Adjusted EPS (Constant Currency)

Adjusted EPS (Constant Currency) represents Adjusted EPS adjusted to eliminate the impact of currency translation.

Covenant Adjusted EBITDA

Covenant Adjusted EBITDA represents net income attributable to Aramark stockholders adjusted for interest and other financing costs, net; provision (benefit) for income taxes; depreciation and amortization; and certain other items as defined in our debt agreements required in calculating covenant ratios and debt compliance. The Company also uses Net Debt for its ratio to Covenant Adjusted EBITDA, which is calculated as total long-term borrowings less cash and cash equivalents.

Free Cash Flow

Free Cash Flow represents net cash provided by operating activities less net purchases of property and equipment and other. Management believes that the presentation of free cash flow provides useful information to investors because it represents a measure of cash flow available for distribution among all the security holders of the Company.

We use Adjusted Revenue, Legacy Business Revenue, Adjusted Operating Income (including on a constant currency basis), Covenant Adjusted EBITDA, Adjusted Net Income (including on a constant currency basis), Adjusted EPS (including on a constant currency basis) and Free Cash Flow as supplemental measures of our operating profitability and to control our cash operating costs. We believe these financial measures are useful to investors because they enable better comparisons of our historical results and allow our investors to evaluate our performance based on the same metrics that we use to evaluate our performance and trends in our results. These financial metrics are not measurements of financial performance under generally accepted accounting principles, or GAAP. Our presentation of these metrics has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. You should not consider these measures as alternatives to revenue, operating income, net income, or earnings per share, determined in accordance with GAAP. Adjusted Revenue, Legacy Business Revenue, Adjusted Operating Income, Covenant Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and Free Cash Flow as presented by us, may not be comparable to other similarly titled measures of other companies because not all companies use identical calculations.

Explanatory Notes to the Non-GAAP Schedules

Amortization of acquisition-related intangible assets - adjustments to eliminate the change in amortization resulting from the purchase accounting applied to the January 26, 2007 going-private transaction executed with investment funds affiliated with GS Capital Partners, CCMP Capital Advisors, LLC and J.P. Morgan Partners, LLC, Thomas H. Lee Partners, L.P. and Warburg Pincus LLC as well as approximately 250 senior management personnel ($7.7 million for the third quarter of 2019, $23.2 million for year-to-date 2019, $7.7 million for the third quarter of 2018 and $30.0 million for year-to-date 2018) and amortization expense recognized on other acquisition-related intangible assets ($20.9 million for the third quarter of 2019, $64.5 million for year-to-date 2019, $21.8 million for the third quarter of 2018 and $49.0 million for year-to-date 2018).

Severance and other charges - adjustments to eliminate severance expenses and other costs incurred in the applicable period related to streamlining initiatives ($2.2 million net expense reduction for the third quarter of 2019, $19.8 million for year-to-date 2019, $0.1 million for the third quarter of 2018 and $39.7 million for year-to-date 2018), adjustments to eliminate consulting costs incurred in the applicable period related to streamlining and general administrative initiatives ($4.5 million for the third quarter of 2019, $13.0 million for year-to-date 2019, $5.3 million for the third quarter of 2018 and $17.3 million for year-to-date 2018), incurring duplicate rent charges, moving costs, opening costs to build out and ready the Company's new headquarters while occupying its existing headquarters and closing costs ($8.4 million for year-to-date 2019, $2.5 million for the third quarter of 2018 and $4.9 million for year-to-date 2018), incurring charges related to information technology related initiatives ($2.5 million for the third quarter of 2019 and $6.2 million for year-to-date 2019) and other charges ($1.0 million for the third quarter of 2018 and $3.6 million for year-to-date 2018).

Effects of divestitures - adjustments to eliminate the impact that the Healthcare Technologies divestiture had on comparative periods.

Merger and Integration Related Charges - adjustments to eliminate merger and integration charges primarily related to the Avendra and AmeriPride acquisitions, including deal costs, costs for transitional employees and integration related consulting costs ($8.0 million for the third quarter of 2019, $26.3 million for year-to-date 2019, $9.7 million for the third quarter of 2018 and $64.8 million for year-to-date 2018).

Gain on sale of Healthcare Technologies - adjustment to eliminate the impact of the gain on sale of the Healthcare Technologies business.

Tax Reform Related Employee Reinvestments - adjustments to eliminate certain reinvestments associated with tax savings created by the Tax Cuts and Jobs Act of 2017, including employee training expenses, special recognition awards and retirement contributions ($5.0 million for the third quarter of 2019 and $70.5 million for year-to-date 2019).

Gains, losses and settlements impacting comparability - adjustments to eliminate certain transactions that are not indicative of our ongoing operational performance, primarily for income/loss from prior years' loss experience under our casualty insurance program ($11.3 million gain for year-to-date 2019 and $18.2 million gain for year-to-date 2018), settlement charges related to exiting a joint venture arrangement ($4.5 million for year-to-date 2019), pension plan charges ($1.2 million for year-to-date 2019, $0.4 million for the third quarter of 2018 and $2.5 million for year-to-date 2018), banker fees and other charges related to the sale of Healthcare Technologies ($0.7 million net expense reduction for the third quarter of 2019 and $7.7 million for year-to-date 2019), charges related to a joint venture liquidation and acquisition ($1.9 million for the third quarter of 2018 and $7.5 million year-to-date 2018), the impact of the change in fair value related to certain gasoline and diesel agreements ($0.5 million gain for the third quarter of 2019 and $3.9 million loss for year-to-date 2019, $0.2 million gain for the third quarter of 2018 and $0.5 million gain for year-to-date 2018) and other charges ($2.3 million for the third quarter of 2019, $2.9 million for year-to-date 2019 and $0.8 million for year-to-date 2018).

Effect of currency translation - adjustments to eliminate the impact that fluctuations in currency translation rates had on the comparative results by presenting the periods on a constant currency basis. Assumes constant foreign currency exchange rates based on the rates in effect for the prior year period being used in translation for the comparable current year period.

Effect of refinancing and other on interest and other financing costs, net - adjustments to eliminate expenses associated with refinancing activities undertaken by the Company in the applicable period such as third party costs and non-cash charges for the write-offs of deferring financing costs and debt discounts and other pension plan charges.

Effect of tax reform on provision for income taxes - adjustments to eliminate the impact of tax reform that is not indicative of our ongoing tax position based on the new tax policies and certain other adjustments.

Tax Impact of Adjustments to Adjusted Net Income - adjustments to eliminate the net tax impact of the adjustments to adjusted net income calculated based on a blended U.S. federal and state tax rate for U.S. adjustments and the local country tax rate for adjustments in jurisdictions outside the U.S.

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect our current views as to future events and financial performance with respect to, without limitation, conditions in our industry, our operations, our economic performance and financial condition, including, in particular, statements made by our Chairman, President, and CEO and under the heading "2019 Outlook" and including with respect to, without limitation, anticipated effects of our adoption of new accounting standards, the expected impact of strategic portfolio actions, the benefits and costs of our acquisitions of each of Avendra, LLC ("Avendra") and AmeriPride Services, Inc. ("AmeriPride"), as well as statements regarding these companies’ services and products and statements relating to our business and growth strategy. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as "outlook," "aim," "anticipate," "are or remain or continue to be confident," "have confidence," "estimate," "expect," "will be," "will continue," "will likely result," "project," "intend," "plan," "believe," "see," "look to" and other words and terms of similar meaning or the negative versions of such words.

Forward-looking statements speak only as of the date made. All statements we make relating to our estimated and projected earnings, costs, expenditures, cash flows, growth rates, financial results and our estimated benefits and costs of our acquisitions are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements. Some of the factors that we believe could affect our results or the costs and benefits of the acquisitions include without limitation: unfavorable economic conditions; natural disasters, global calamities, sports strikes and other adverse incidents; the failure to retain current clients, renew existing client contracts and obtain new client contracts; a determination by clients to reduce their outsourcing or use of preferred vendors; competition in our industries; increased operating costs and obstacles to cost recovery due to the pricing and cancellation terms of our food and support services contracts; the inability to achieve cost savings through our cost reduction efforts; our expansion strategy; the failure to maintain food safety throughout our supply chain, food-borne illness concerns and claims of illness or injury; governmental regulations including those relating to food and beverages, the environment, wage and hour and government contracting; liability associated with noncompliance with applicable law or other governmental regulations; new interpretations of or changes in the enforcement of the government regulatory framework; currency risks and other risks associated with international operations, including Foreign Corrupt Practices Act, U.K. Bribery Act and other anti-corruption law compliance; continued or further unionization of our workforce; liability resulting from our participation in multiemployer defined benefit pension plans; risks associated with suppliers from whom our products are sourced; disruptions to our relationship with, or to the business of, our primary distributor; the inability to hire and retain sufficient qualified personnel or increases in labor costs; healthcare reform legislation; the contract intensive nature of our business, which may lead to client disputes; seasonality; disruptions in the availability of our computer systems or privacy breaches; failure to achieve and maintain effective internal controls; our leverage; the inability to generate sufficient cash to service all of our indebtedness; debt agreements that limit our flexibility in operating our business; our ability to successfully integrate the businesses of Avendra and AmeriPride and costs and timing related thereto, the risk of unanticipated restructuring costs or assumption of undisclosed liabilities, the risk that we are unable to achieve the anticipated benefits (including tax benefits) and synergies of the acquisition of AmeriPride and Avendra including whether the transactions will be accretive and within the expected timeframes, the availability of sufficient cash to repay certain indebtedness and our decision to utilize the cash for that purpose, the disruption of the transactions to each of Avendra and AmeriPride and their respective managements; the effect of the transactions on each of Avendra's and AmeriPride's ability to retain and hire key personnel and maintain relationships with customers, suppliers and other third parties, our ability to attract new or maintain existing customer and supplier relationships at reasonable cost, our ability to retain key personnel and other factors set forth under the headings Item 1A "Risk Factors," Item 3 "Legal Proceedings" and Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" and other sections of our Annual Report on Form 10-K, filed with the SEC on November 21, 2018 as such factors may be updated from time to time in our other periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov and which may be obtained by contacting Aramark's investor relations department via its website www.aramark.com. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in our other filings with the SEC. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included herein or that may be made elsewhere from time to time by, or on behalf of, us. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, changes in our expectations, or otherwise, except as required by law.

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In Thousands, Except Per Share Amounts)

 

 

 

Three Months Ended

 

 

June 28, 2019

 

June 29, 2018

Revenue

 

$

4,010,761

 

 

$

3,971,606

 

Costs and Expenses:

 

 

 

 

Cost of services provided

 

3,594,978

 

 

3,526,293

 

Depreciation and amortization

 

148,779

 

 

156,934

 

Selling and general corporate expenses

 

78,185

 

 

101,715

 

 

 

3,821,942

 

 

3,784,942

 

Operating income

 

188,819

 

 

186,664

 

Interest and Other Financing Costs, net

 

82,220

 

 

89,776

 

Income Before Income Taxes

 

106,599

 

 

96,888

 

Provision for Income Taxes

 

23,535

 

 

24,172

 

Net income

 

83,064

 

 

72,716

 

Less: Net income attributable to noncontrolling interest

 

109

 

 

139

 

Net income attributable to Aramark stockholders

 

$

82,955

 

 

$

72,577

 

 

 

 

 

 

Earnings per share attributable to Aramark stockholders:

 

 

 

 

Basic

 

$

0.34

 

 

$

0.29

 

Diluted

 

$

0.33

 

 

$

0.29

 

Weighted Average Shares Outstanding:

 

 

 

 

Basic

 

246,928

 

 

246,028

 

Diluted

 

251,147

 

 

251,857

 

 

 

Nine Months Ended

 

 

June 28, 2019

 

June 29, 2018

Revenue

 

$

12,276,097

 

 

$

11,876,035

 

Costs and Expenses:

 

 

 

 

Cost of services provided

 

11,029,382

 

 

10,611,532

 

Depreciation and amortization

 

447,408

 

 

443,646

 

Selling and general corporate expenses

 

270,600

 

 

282,327

 

Gain on sale of Healthcare Technologies

 

(156,309

)

 

 

 

 

11,591,081

 

 

11,337,505

 

Operating income

 

685,016

 

 

538,530

 

Interest and Other Financing Costs, net

 

249,375

 

 

256,562

 

Income Before Income Taxes

 

435,641

 

 

281,968

 

(Benefit) Provision for Income Taxes

 

72,589

 

 

(110,904

)

Net income

 

363,052

 

 

392,872

 

Less: Net income attributable to noncontrolling interest

 

60

 

 

442

 

Net income attributable to Aramark stockholders

 

$

362,992

 

 

$

392,430

 

 

 

 

 

 

Earnings per share attributable to Aramark stockholders:

 

 

 

 

Basic

 

$

1.47

 

 

$

1.60

 

Diluted

 

$

1.44

 

 

$

1.56

 

Weighted Average Shares Outstanding:

 

 

 

 

Basic

 

246,665

 

 

245,588

 

Diluted

251,271

252,231

 

 

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS*

(Unaudited)

(In Thousands)

 

 

 

 

 

 

 

June 28, 2019

 

September 28, 2018

Assets

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

Cash and cash equivalents

 

$

220,055

 

 

$

215,025

 

Receivables

 

1,832,911

 

 

1,790,433

 

Inventories

 

393,115

 

 

724,802

 

Prepayments and other current assets

 

196,044

 

 

171,165

 

Total current assets

 

2,642,125

 

 

2,901,425

 

Property and Equipment, net

 

2,143,765

 

 

1,378,094

 

Goodwill

 

5,526,301

 

 

5,610,568

 

Other Intangible Assets

 

2,064,637

 

 

2,136,844

 

Other Assets

 

1,352,674

 

 

1,693,171

 

 

 

$

13,729,502

 

 

$

13,720,102

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

Current maturities of long-term borrowings

 

$

53,749

 

 

$

30,907

 

Accounts payable

 

819,922

 

 

1,018,920

 

Accrued expenses and other current liabilities

 

1,285,725

 

 

1,440,332

 

Total current liabilities

 

2,159,396

 

 

2,490,159

 

Long-Term Borrowings

 

7,198,918

 

 

7,213,077

 

Deferred Income Taxes and Other Noncurrent Liabilities

 

1,075,198

 

 

977,215

 

Redeemable Noncontrolling Interest

 

10,068

 

 

10,093

 

Total Stockholders' Equity

 

3,285,922

 

 

3,029,558

 

 

 

$

13,729,502

 

 

$

13,720,102

 

 

 

 

 

 

* In connection with the Company's adoption of ASC 606, Revenue from Contracts with Customers, the classification of certain balance sheet line items has been adjusted as of June 28, 2019, including Inventories, Property and Equipment, net and Other Assets. Further details will be available in the Quarterly Report on Form 10-Q for the quarterly period ended June 28, 2019.

 

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In Thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

June 28, 2019

 

June 29, 2018

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

Net income

 

$

363,052

 

 

$

392,872

 

Adjustments to reconcile net income to net cash provided by operating activities

 

 

 

 

Depreciation and amortization

 

447,408

 

 

443,646

 

Deferred income taxes

 

21,861

 

 

(155,050

)

Share-based compensation expense

 

48,414

 

 

68,318

 

Net gain on sale of Healthcare Technologies

 

(139,165

)

 

 

Changes in operating assets and liabilities

 

(501,944

)

 

(597,182

)

Payments made to clients on contracts1

 

(30,169

)

 

 

Other operating activities

 

(1,270

)

 

(7,092

)

Net cash provided by operating activities

 

208,187

 

 

145,512

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

Net purchases of property and equipment and other

 

(329,429

)

 

(425,093

)

Acquisitions, divestitures and other investing activities

 

280,037

 

 

(2,247,086

)

Net cash used in investing activities

 

(49,392

)

 

(2,672,179

)

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

Net proceeds/payments of long-term borrowings

 

(264,372

)

 

2,445,007

 

Net change in funding under the Receivables Facility

 

255,000

 

 

145,800

 

Payments of dividends

 

(81,305

)

 

(77,317

)

Proceeds from issuance of common stock

 

21,339

 

 

15,961

 

Repurchase of stock

 

(50,000

)

 

(24,410

)

Other financing activities

 

(31,322

)

 

(47,113

)

Net cash provided by (used in) financing activities

 

(150,660

)

 

2,457,928

 

Effect of foreign exchange rates on cash and cash equivalents

 

(3,105

)

 

(4,090

)

Increase (decrease) in cash and cash equivalents

 

5,030

 

 

(72,829

)

Cash and cash equivalents, beginning of period

 

215,025

 

 

238,797

 

Cash and cash equivalents, end of period

 

$

220,055

 

 

$

165,968

 

 

1Prior to the Company's adoption of ASC 606 Revenue from Contracts with Customers certain client contract investments were included within "Net purchases of property and equipment and other" in Net cash used in investing activities. Subsequent to adoption of ASC 606 these costs are now included within "Payments made to clients on contracts" in Net cash provided by operating activities.

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

ADJUSTED CONSOLIDATED OPERATING INCOME MARGIN

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

June 28, 2019

 

 

FSS United States

 

FSS International

 

Uniform

 

Corporate

 

Aramark and
Subsidiaries

Revenue (as reported)

 

$

2,413,503

 

 

$

949,862

 

 

$

647,396

 

 

 

 

$

4,010,761

 

Operating Income (as reported)

 

$

127,873

 

 

$

40,157

 

 

$

53,609

 

 

$

(32,820

)

 

$

188,819

 

Operating Income Margin (as reported)

 

5.30

%

 

4.23

%

 

8.28

%

 

 

 

4.71

%

 

 

 

 

 

 

 

 

 

 

 

Revenue (as reported)

 

$

2,413,503

 

 

$

949,862

 

 

$

647,396

 

 

 

 

$

4,010,761

 

Effect of Currency Translation

 

1,825

 

 

73,331

 

 

2,030

 

 

 

 

77,186

 

Adjusted Revenue

 

$

2,415,328

 

 

$

1,023,193

 

 

$

649,426

 

 

 

 

$

4,087,947

 

Revenue Growth (as reported)

 

(3.50

)%

 

2.15

%

 

19.73

%

 

 

 

0.99

%

Adjusted Revenue Growth

 

0.91

%

 

10.04

%

 

20.10

%

 

 

 

5.79

%

 

 

 

 

 

 

 

 

 

 

 

Operating Income (as reported)

 

$

127,873

 

 

$

40,157

 

 

$

53,609

 

 

$

(32,820

)

 

$

188,819

 

Amortization of Acquisition-Related Intangible Assets

 

21,059

 

 

1,487

 

 

6,139

 

 

 

 

28,685

 

Severance and Other Charges

 

642

 

 

 

 

 

 

4,208

 

 

4,850

 

Merger and Integration Related Charges

 

2,238

 

 

 

 

5,798

 

 

 

 

8,036

 

Tax Reform Related Employee Reinvestments

 

3,627

 

 

 

 

1,440

 

 

 

 

5,067

 

Gains, Losses and Settlements impacting comparability

 

615

 

 

965

 

 

 

 

(425

)

 

1,155

 

Adjusted Operating Income*

 

$

156,054

 

 

$

42,609

 

 

$

66,986

 

 

$

(29,037

)

 

$

236,612

 

Effect of Currency Translation

 

413

 

 

2,931

 

 

124

 

 

 

 

3,468

 

Adjusted Operating Income (Constant Currency)

 

$

156,467

 

 

$

45,540

 

 

$

67,110

 

 

$

(29,037

)

 

$

240,080

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income Growth (as reported)

 

(5.76

)%

 

(8.08

)%

 

(5.53

)%

 

33.63

%

 

1.15

%

Adjusted Operating Income Growth

 

0.37

%

 

(9.96

)%

 

(4.18

)%

 

31.12

%

 

2.63

%

Adjusted Operating Income Growth (Constant Currency)

 

0.64

%

 

(3.77

)%

 

(4.00

)%

 

31.12

%

 

4.13

%

Adjusted Operating Income Margin (Constant Currency)

 

6.48

%

 

4.45

%

 

10.33

%

 

 

 

5.87

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

June 29, 2018

 

 

FSS United States

 

FSS International

 

Uniform

 

Corporate

 

Aramark and
Subsidiaries

Revenue (as reported)

 

$

2,501,000

 

 

$

929,875

 

 

$

540,731

 

 

 

 

$

3,971,606

 

Effect of Divestitures

 

(107,462

)

 

 

 

 

 

 

 

(107,462

)

Adjusted Revenue

 

$

2,393,538

 

 

$

929,875

 

 

$

540,731

 

 

 

 

$

3,864,144

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income (as reported)

 

$

135,682

 

 

$

43,685

 

 

$

56,745

 

 

$

(49,448

)

 

$

186,664

 

Amortization of Acquisition-Related Intangible Assets

 

21,569

 

 

1,564

 

 

6,310

 

 

 

 

29,443

 

Severance and Other Charges

 

3,595

 

 

149

 

 

 

 

5,313

 

 

9,057

 

Effect of Divestitures

 

(7,750

)

 

 

 

 

 

 

 

(7,750

)

Merger and Integration Related Charges

 

1,970

 

 

 

 

6,851

 

 

2,186

 

 

11,007

 

Gains, Losses and Settlements impacting comparability

 

410

 

 

1,926

 

 

 

 

(205

)

 

2,131

 

Adjusted Operating Income*

 

$

155,476

 

 

$

47,324

 

 

$

69,906

 

 

$

(42,154

)

 

$

230,552

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income Margin (as reported)

 

5.43

%

 

4.70

%

 

10.49

%

 

 

 

4.70

%

Adjusted Operating Income Margin

 

6.50

%

 

5.09

%

 

12.93

%

 

 

 

5.97

%

 

 

 

 

 

 

 

 

 

 

 

* Beginning in fiscal 2019, the definition of AOI changed. AOI for the three months ended June 29, 2018 has been calculated based on this new definition. See page 5 for the new definition of AOI.

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

ADJUSTED CONSOLIDATED OPERATING INCOME MARGIN

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

June 28, 2019

 

 

FSS United States

 

FSS International

 

Uniform

 

Corporate

 

Aramark and
Subsidiaries

Revenue (as reported)

 

$

7,490,818

 

 

$

2,845,045

 

 

$

1,940,234

 

 

 

 

$

12,276,097

 

Operating Income (as reported)

 

$

560,439

 

 

$

93,512

 

 

$

144,501

 

 

$

(113,436

)

 

$

685,016

 

Operating Income Margin (as reported)

 

7.48

%

 

3.29

%

 

7.45

%

 

 

 

5.58

%

 

 

 

 

 

 

 

 

 

 

 

Revenue (as reported)

 

$

7,490,818

 

 

$

2,845,045

 

 

$

1,940,234

 

 

 

 

$

12,276,097

 

Effect of Currency Translation

 

6,040

 

 

212,826

 

 

7,274

 

 

 

 

226,140

 

Adjusted Revenue

 

$

7,496,858

 

 

$

3,057,871

 

 

$

1,947,508

 

 

 

 

$

12,502,237

 

Revenue Growth (as reported)

 

(2.17

)%

 

2.78

%

 

33.73

%

 

 

 

3.37

%

Adjusted Revenue Growth

 

1.52

%

 

10.47

%

 

34.23

%

 

 

 

7.74

%

 

 

 

 

 

 

 

 

 

 

 

Operating Income (as reported)

 

$

560,439

 

 

$

93,512

 

 

$

144,501

 

 

$

(113,436

)

 

$

685,016

 

Amortization of Acquisition-Related Intangible Assets

 

65,487

 

 

3,975

 

 

18,273

 

 

 

 

87,735

 

Severance and Other Charges

 

14,589

 

 

17,945

 

 

493

 

 

14,461

 

 

47,488

 

Merger and Integration Related Charges

 

5,520

 

 

 

 

20,788

 

 

8

 

 

26,316

 

Gain on sale of Healthcare Technologies

 

(156,309

)

 

 

 

 

 

 

 

(156,309

)

Tax Reform Related Employee Reinvestments

 

55,429

 

 

352

 

 

13,298

 

 

1,443

 

 

70,522

 

Gains, Losses and Settlements impacting comparability

 

(4,661

)

 

3,507

 

 

 

 

10,006

 

 

8,852

 

Adjusted Operating Income*

 

$

540,494

 

 

$

119,291

 

 

$

197,353

 

 

$

(87,518

)

 

$

769,620

 

Effect of Currency Translation

 

1,244

 

 

8,182

 

 

650

 

 

 

 

10,076

 

Adjusted Operating Income (Constant Currency)

 

$

541,738

 

 

$

127,473

 

 

$

198,003

 

 

$

(87,518

)

 

$

779,696

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income Growth (as reported)

 

23.54

%

 

(7.82

)%

 

10.12

%

 

23.24

%

 

27.20

%

Adjusted Operating Income Growth

 

4.86

%

 

(12.59

)%

 

16.49

%

 

14.32

%

 

7.01

%

Adjusted Operating Income Growth (Constant Currency)

 

5.10

%

 

(6.60

)%

 

16.87

%

 

14.32

%

 

8.41

%

Adjusted Operating Income Margin (Constant Currency)

 

7.23

%

 

4.17

%

 

10.17

%

 

 

 

6.24

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

June 29, 2018

 

 

FSS United States

 

FSS International

 

Uniform

 

Corporate

 

Aramark and
Subsidiaries

Revenue (as reported)

 

$

7,656,979

 

 

$

2,768,157

 

 

$

1,450,899

 

 

 

 

$

11,876,035

 

Effect of Divestitures

 

(272,114

)

 

 

 

 

 

 

 

(272,114

)

Adjusted Revenue

 

$

7,384,865

 

 

$

2,768,157

 

 

$

1,450,899

 

 

 

 

$

11,603,921

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income (as reported)

 

$

453,643

 

 

$

101,445

 

 

$

131,220

 

 

$

(147,778

)

 

$

538,530

 

Amortization of Acquisition-Related Intangible Assets

 

64,183

 

 

3,572

 

 

11,240

 

 

 

 

78,995

 

Severance and Other Charges

 

21,909

 

 

23,549

 

 

1,571

 

 

18,504

 

 

65,533

 

Effect of Divestitures

 

(22,065

)

 

 

 

 

 

 

 

(22,065

)

Merger and Integration Related Charges

 

11,656

 

 

 

 

27,137

 

 

27,345

 

 

66,138

 

Gains, Losses and Settlements impacting comparability

 

(13,879

)

 

7,912

 

 

(1,746

)

 

(221

)

 

(7,934

)

Adjusted Operating Income*

 

$

515,447

 

 

$

136,478

 

 

$

169,422

 

 

$

(102,150

)

 

$

719,197

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income Margin (as reported)

 

5.92

%

 

3.66

%

 

9.04

%

 

 

 

4.53

%

Adjusted Operating Income Margin

 

6.98

%

 

4.93

%

 

11.68

%

 

 

 

6.20

%

 

* Beginning in fiscal 2019, the definition of AOI changed. AOI for the nine months ended June 29, 2018 has been calculated based on this new definition. See page 5 for the new definition of AOI.

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

ADJUSTED NET INCOME & ADJUSTED EPS

(Unaudited)

(In thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

June 28, 2019

 

June 29, 2018

 

June 28, 2019

 

June 29, 2018

 

 

 

 

 

 

 

 

 

Net Income Attributable to Aramark Stockholders (as reported)

 

$

82,955

 

 

$

72,577

 

 

$

362,992

 

 

$

392,430

 

Adjustment:

 

 

 

 

 

 

 

 

Amortization of Acquisition-Related Intangible Assets

 

28,685

 

 

29,443

 

 

87,735

 

 

78,995

 

Severance and Other Charges

 

4,850

 

 

9,057

 

 

47,488

 

 

65,533

 

Effect of Divestitures

 

 

 

(7,750

)

 

 

 

(22,065

)

Merger and Integration Related Charges

 

8,036

 

 

11,007

 

 

26,316

 

 

66,138

 

Gain on sale of Healthcare Technologies

 

 

 

 

 

(156,309

)

 

 

Tax Reform Related Employee Reinvestments

 

5,067

 

 

 

 

70,522

 

 

 

Gains, Losses and Settlements impacting comparability

 

1,155

 

 

2,131

 

 

8,852

 

 

(7,934

)

Effects of Refinancing and Other on Interest and Other Financing Costs, net

 

 

 

1,082

 

 

 

 

19,925

 

Effect of Tax Reform on Provision for Income Taxes

 

 

 

 

 

(12,126

)

 

(183,808

)

Tax Impact of Adjustments to Adjusted Net Income

 

(11,915

)

 

(12,707

)

 

(44,298

)

 

(48,881

)

Adjusted Net Income

 

$

118,833

 

 

$

104,840

 

 

$

391,172

 

 

$

360,333

 

Effect of Currency Translation, net of Tax

 

2,393

 

 

 

 

7,488

 

 

 

Adjusted Net Income (Constant Currency)

 

$

121,226

 

 

$

104,840

 

 

$

398,660

 

 

$

360,333

 

 

 

 

 

 

 

 

 

 

Earnings Per Share (as reported)

 

 

 

 

 

 

 

 

Net Income Attributable to Aramark Stockholders (as reported)

 

$

82,955

 

 

$

72,577

 

 

$

362,992

 

 

$

392,430

 

Diluted Weighted Average Shares Outstanding

 

251,147

 

 

251,857

 

 

251,271

 

 

252,231

 

 

 

$

0.33

 

 

$

0.29

 

 

$

1.44

 

 

$

1.56

 

Earnings Per Share Growth (as reported)

 

13.79

%

 

 

 

(7.69

)%

 

 

 

 

 

 

 

 

 

 

 

Adjusted Earnings Per Share

 

 

 

 

 

 

 

 

Adjusted Net Income*

 

$

118,833

 

 

$

104,840

 

 

$

391,172

 

 

$

360,333

 

Diluted Weighted Average Shares Outstanding

 

251,147

 

 

251,857

 

 

251,271

 

 

252,231

 

 

 

$

0.47

 

 

$

0.42

 

 

$

1.56

 

 

$

1.43

 

Adjusted Earnings Per Share Growth

 

11.90

%

 

 

 

9.09

%

 

 

 

 

 

 

 

 

 

 

 

Adjusted Earnings Per Share (Constant Currency)

 

 

 

 

 

 

 

 

Adjusted Net Income (Constant Currency)

 

$

121,226

 

 

$

104,840

 

 

$

398,660

 

 

$

360,333

 

Diluted Weighted Average Shares Outstanding

 

251,147

 

 

251,857

 

 

251,271

 

 

252,231

 

 

 

$

0.48

 

 

$

0.42

 

 

$

1.59

 

 

$

1.43

 

Adjusted Earnings Per Share Growth (Constant Currency)

 

14.29

%

 

 

 

11.19

%

 

 

 

* Beginning in fiscal 2019, the definition of Adjusted Net Income changed. Adjusted Net Income for the three and nine months ended June 29, 2018 has been calculated based on this new definition. See page 5 for the new definition of Adjusted Net Income.

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

NET DEBT TO COVENANT ADJUSTED EBITDA

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

Twelve Months Ended

 

 

June 28, 2019

 

June 29, 2018

 

 

 

 

 

Net Income Attributable to Aramark Stockholders (as reported)

 

$

538,445

 

 

$

505,568

 

Interest and Other Financing Costs, net

 

341,919

 

 

324,341

 

(Benefit) Provision for Income Taxes

 

86,932

 

 

(68,783

)

Depreciation and Amortization

 

599,944

 

 

573,601

 

Share-based compensation expense(1)

 

68,372

 

 

83,154

 

Unusual or non-recurring (gains) and losses(2)

 

(156,309

)

 

 

Pro forma EBITDA for equity method investees(3)

 

12,517

 

 

16,168

 

Pro forma EBITDA for certain transactions(4)

 

19,750

 

 

105,424

 

Other(5)

 

191,841

 

 

133,936

 

Covenant Adjusted EBITDA

 

$

1,703,411

 

 

$

1,673,409

 

 

 

 

 

 

Net Debt to Covenant Adjusted EBITDA

 

 

 

 

Total Long-Term Borrowings

 

$

7,252,667

 

 

$

7,870,305

 

Less: Cash and cash equivalents

 

$

220,055

 

 

$

165,968

 

Net Debt

 

$

7,032,612

 

 

$

7,704,337

 

Covenant Adjusted EBITDA

 

$

1,703,411

 

 

$

1,673,409

 

Net Debt/Covenant Adjusted EBITDA

 

4.1

 

 

4.6

 

 

(1) Represents compensation expense related to the Company's issuances of share-based awards.

(2) Represents the gain from the divestiture of Healthcare Technologies.

(3) Represents our estimated share of EBITDA primarily from our AIM Services Co., Ltd. equity method investment, not already reflected in our net income attributable to Aramark stockholders. EBITDA for this equity method investee is calculated in a manner consistent with Covenant Adjusted EBITDA but does not represent cash distributions received from this investee.

(4) Represents the annualizing of net EBITDA from certain acquisitions and divestitures made during the period.

(5) "Other" for the twelve months ended June 28, 2019 and June 29, 2018, respectively, includes organizational streamlining initiatives ($16.7 million costs and $40.6 million costs), the impact of the change in fair value related to certain gasoline and diesel agreements ($4.2 million loss and $4.1 million gain), expenses related to merger and integration related charges ($39.6 million and $66.9 million), duplicate rent charges, moving costs, opening costs to build out and ready the Company's new headquarters while occupying its existing headquarters and closing costs ($11.1 million and $4.9 million) and other miscellaneous expenses. "Other" for the twelve months ended June 28, 2019 also includes compensation expense for employee reinvestments funded by benefits from U.S. tax reform ($70.5 million), adjustments to remove the impact attributable to the adoption of certain new accounting standards, including Accounting Standards Codification 606, Revenue from Contracts with Customers, in accordance with the Credit Agreement and indentures ($16.2 million), banker fees and other charges related to the sale of Healthcare Technologies ($8.0 million), closing costs mainly related to customer contracts ($8.5 million), certain environmental charges ($5.0 million), settlement charges related to exiting a joint venture arrangement ($4.5 million) and the impact of hyperinflation in Argentina ($3.8 million). "Other" for the twelve months ended June 29, 2018 also includes the estimated impact of natural disasters, net of insurance proceeds ($13.3 million, of which $6.1 million related to asset write-downs) and property and other asset write-downs related to a joint venture liquidation and acquisition ($7.5 million).

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

LEGACY BUSINESS REVENUE

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

June 28, 2019

 

 

FSS United States

 

FSS International

 

Uniform

 

Aramark and
Subsidiaries

Revenue (as reported)

 

$

2,413,503

 

 

$

949,862

 

 

$

647,396

 

 

$

4,010,761

 

Effect of Currency Translation

 

1,825

 

 

73,331

 

 

2,030

 

 

77,186

 

Adjusted Revenue

 

$

2,415,328

 

 

$

1,023,193

 

 

$

649,426

 

 

$

4,087,947

 

Changes pursuant to ASC 606, Revenue from Contracts with Customers

 

13,431

 

 

(2,022

)

 

(91,752

)

 

(80,343

)

Legacy Business Revenue

 

$

2,428,759

 

 

$

1,021,171

 

 

$

557,674

 

 

$

4,007,604

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

June 29, 2018

 

 

FSS United States

 

FSS International

 

Uniform

 

Aramark and
Subsidiaries

Revenue (as reported)

 

$

2,501,000

 

 

$

929,875

 

 

$

540,731

 

 

$

3,971,606

 

Effect of Divestitures

 

(107,462

)

 

 

 

 

 

(107,462

)

Legacy Business Revenue

 

$

2,393,538

 

 

$

929,875

 

 

$

540,731

 

 

$

3,864,144

 

 

 

 

 

 

 

 

 

 

Revenue Growth (as reported)

 

(3.50

)%

 

2.15

%

 

19.73

%

 

0.99

%

Legacy Business Revenue Growth

 

1.47

%

 

9.82

%

 

3.13

%

 

3.71

%

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

June 28, 2019

 

 

FSS United States

 

FSS International

 

Uniform

 

Aramark and
Subsidiaries

Revenue (as reported)

 

$

7,490,818

 

 

$

2,845,045

 

 

$

1,940,234

 

 

$

12,276,097

 

Effect of Currency Translation

 

6,040

 

 

212,826

 

 

7,274

 

 

226,140

 

Adjusted Revenue

 

$

7,496,858

 

 

$

3,057,871

 

 

$

1,947,508

 

 

$

12,502,237

 

Effect of AmeriPride and Avendra Acquisitions

 

(30,768

)

 

 

 

(167,616

)

 

(198,384

)

Changes pursuant to ASC 606, Revenue from Contracts with Customers

 

28,469

 

 

(6,067

)

 

(282,835

)

 

(260,433

)

Legacy Business Revenue

 

$

7,494,559

 

 

$

3,051,804

 

 

$

1,497,057

 

 

$

12,043,420

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

June 29, 2018

 

 

FSS United States

 

FSS International

 

Uniform

 

Aramark and
Subsidiaries

Revenue (as reported)

 

$

7,656,979

 

 

$

2,768,157

 

 

$

1,450,899

 

 

$

11,876,035

 

Effect of Divestitures

 

(272,114

)

 

 

 

 

 

(272,114

)

Legacy Business Revenue

 

$

7,384,865

 

 

$

2,768,157

 

 

$

1,450,899

 

 

$

11,603,921

 

 

 

 

 

 

 

 

 

 

Revenue Growth (as reported)

 

(2.17

)%

 

2.78

%

 

33.73

%

 

3.37

%

Legacy Business Revenue Growth

 

1.49

%

 

10.25

%

 

3.18

%

 

3.79

%

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

FREE CASH FLOW

(Unaudited)

(In thousands)

 

 

 

 

 

Nine Months Ended

 

June 28, 2019

 

June 29, 2018

Net Cash provided by operating activities

$

208,187

 

 

$

145,512

 

 

 

 

 

Net purchases of property and equipment and other

(329,429

)

 

(425,093

)

 

 

 

 

Free Cash Flow

$

(121,242

)

 

$

(279,581

)

 

 

Contacts

Media Inquiries:
Karen Cutler
(215) 238-4063
Cutler-Karen@aramark.com

Investor Inquiries:
Felise Kissell
(215) 409-7287
Kissell-Felise@aramark.com

Release Summary

Aramark reports Q3 fiscal earnings results

$Cashtags

Social Media Profiles

Contacts

Media Inquiries:
Karen Cutler
(215) 238-4063
Cutler-Karen@aramark.com

Investor Inquiries:
Felise Kissell
(215) 409-7287
Kissell-Felise@aramark.com